Cancer, seizures and HIV/AIDS symptoms – marijuana has proven to be a viable option for treatment use in all of these medical conditions. Another medical condition added to that list is Parkinson’s Disease (PD); the motor and non-motor symptoms of PD, to be specific. (1) Parkinson’s Disease is a neurodegenerative disorder that affects primarily dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra. PD symptoms include slowness of movement (or “bradykinesia”), stiffness of the arms or legs, involuntary shaking (mainly at rest) and a few others.

(2) A 2011 to 2012 open-label observational study of 22 PD patients who were evaluated at both baseline and 30 minutes after smoking marijuana, produced magnificent results in favor of cannabis. The mean (SD) total score on the motor Unified Parkinson Disease Rating Scale showed significant improvement in those 22 patients post cannabis treatment, from 33.1 (13.8) at baseline to 23.2 (10.5) in terms treating their tremors, rigidity and bradykinesia. The study also revealed that the 22 PD patients, after smoking marijuana, experienced better quality of sleep and improved pain scores.

It’s absolutely amazing what this plant currently does and can do, for the medical field. The data found in this study helps individuals suffering from Parkinson’s Disease consider another method of treating their symptoms outside of Benztropine (anti-tremor drug) and Ropinirole. Marijuana provides an alternative to pills and tablets – one of its many traits.

We are in no way, shape or form encouraging any individuals to use this article to attempt to or validate self-medication. We strongly recommend everyone seek medical attention and consult with a medical professional prior to any type of treatment.


1.) What is Parkinson’s?. Parkinson’s Foundation.

2.) Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease: An Open-Label Observational Study.
Lotan, Itay MD; Treves, Therese A. MD; Roditi, Yaniv MD; Djaldetti, Ruth MD.
Clinical Neuropharmacology: March/April 2014 – Volume 37 – Issue 2 – p 41–44.


Leave a reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Contact Us

We're here to help! Just send us an email and we'll get back to you ASAP :)


©2019 CBD Social Network


Log in with your credentials


Forgot your details?


Create Account